The families of 65 patients with systemic sclerosis were examined clinically and serum samples from each subject were tested for antinuclear antibodies (ANA) by immunofluorescence on HEp2 cells and for precipitating antibodies to soluble cellular antigens including Of 217 blood relatives, 58 (27%) had ANA (42 speckled, 13 nucleolar, one centromere, two homogeneous); 22 (10%) had precipitins, one anti-Scl-70, one anti-PM-Scl, one anti-nRNP, two anti-Ro(SSA), the remainder unidentified). Family members tended to share ANA patterns. Of 38 spouses, nine (24%) had ANA (all speckled) and two showed unidentified precipitins. This compares with an incidence of ANA and precipitins in a control population of 8% and 1% respectively. Antibodies were more common in female than male relatives (particularly in mothers and sisters of probands). Twenty one of the 58 family members with ANA had clinical features of connective tissue disease; the remainder were asymptomatic.
proband. In contrast with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), familial cases of SS are uncommon. Nevertheless, there are previous reports of immunological abnormalities in asymptomatic relatives of patients with SS, though the frequency of the findings varies widely in different series.2 23 Furthermore, the demonstration by several groups that certain HLA haplotypes are associated with the disease2427 also suggests that genetic factors might be involved in the development or the expression of SS, or both.
Given the opportunity to study large numbers of patients and family members through the collaborating centres of the UK Systemic Sclerosis Study Group, particularly in the light of increased knowledge of the serolbgical abnormalities in SS, it was the aim of this study to determine the frequency and specificity of ANA in the sera of relatives of patients with SS. Patients With HEp2 cells as substrate ANA were detected in 93% of sera from probands, 27% from blood relatives, and in 24% from spouses ( Fig. 1 ). This compares with 8% in the healthy controls. Fig. 2 shows that the ANA titres were highest in the patients, intermediate in the relatives, and generally 
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]FM low in the ANA positive spouses and healthy controls. Table 2 summarises the patterns of immunofluorescence in the ANA positive sera. Antibodies characteristically found in systemic sclerosis were identified in the sera of blood relatives, especially antinucleolar antibodies, which were present in 22%. In one case anticentromere antibodies were present. Although ANA were more commonly found in spouses of patients than in healthy controls, they were generally of low titre and showed a non-specific speckled pattern of fluorescence. The frequency and specificity of antibodies to soluble non-histone tissue antigens are summarised in Table 3 . Antibodies were detected by immunodiffusion in 57% of the probands, 10% of the blood relatives, and 5% of the spouses, which compares with the incidence of 1% in the healthy controls.
These antibodies were detected to a variety of cellular constituents in the tissue extracts, and in many cases they did not correspond to the reference sera and still remain uncharacterised. As expected, antibodies to Scl-70 represented the most commonly identified precipitin system in the probands and were present in 17% of cases. In two instances antibodies with a high degree of specificity for systemic sclerosis were detected in relatives, anti- 
